<code id='45A50EE670'></code><style id='45A50EE670'></style>
    • <acronym id='45A50EE670'></acronym>
      <center id='45A50EE670'><center id='45A50EE670'><tfoot id='45A50EE670'></tfoot></center><abbr id='45A50EE670'><dir id='45A50EE670'><tfoot id='45A50EE670'></tfoot><noframes id='45A50EE670'>

    • <optgroup id='45A50EE670'><strike id='45A50EE670'><sup id='45A50EE670'></sup></strike><code id='45A50EE670'></code></optgroup>
        1. <b id='45A50EE670'><label id='45A50EE670'><select id='45A50EE670'><dt id='45A50EE670'><span id='45A50EE670'></span></dt></select></label></b><u id='45A50EE670'></u>
          <i id='45A50EE670'><strike id='45A50EE670'><tt id='45A50EE670'><pre id='45A50EE670'></pre></tt></strike></i>

          Home / comprehensive / entertainment

          entertainment


          entertainment

          author:entertainment    Page View:8153
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In